Ticker
SCYXCompany Name
SCYNEXIS INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQDate | Net Income Common Stock | Net Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -19.52M | -599.05% | $ 3.26M |
3/31/2025 | $ -27.09M | -1030.04% | $ 2.63M |
12/31/2024 | $ -21.29M | -568.29% | $ 3.75M |
9/30/2024 | $ -36.44M | -425.41% | $ 8.57M |
6/30/2024 | $ -35.39M | -366.09% | $ 9.67M |
3/31/2024 | $ 101.33M | 72.18% | $ 140.38M |
12/31/2023 | $ 67.04M | 47.84% | $ 140.14M |
9/30/2023 | $ 72.2M | 53.14% | $ 135.87M |
6/30/2023 | $ 44.37M | 32.71% | $ 135.66M |
3/31/2023 | $ -91.23M | -1648.61% | $ 5.53M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Net Inc. Cmn. / Revenues
(=) Net %
Net % for SCYNEXIS INC is calculated as follows: Net Inc. Cmn. [ $ -26.93M ] / Revenues [ $ 0 ]
(=) Net % [ 0% ]
Minimum
Mar 31, 2022
Maximum
Mar 31, 2024
Average
Median
filtered constituents | 3.19K |
---|---|
min | -63.83% |
max | 69.74% |
average | 4.8% |
median | 5.26% |
std | 19.81% |